Articles on ARVs

Displaying all articles

People with a certain gene have an adverse reaction to the antiretroviral efavirenz. Shutterstock

January 29, 2017

How a gene test can solve side effects linked to ARV drugs in Africa

Collen Masimirembwa, University of Cape Town

Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.

South African HIV rights group, the Treatment Action Campaign, marching through Durban, calling for antiretroviral access for all. International AIDS Society/Rogan Ward

July 19, 2016

It will take more than $36 billion every year to end AIDS

Charles Shey Wiysonge, Stellenbosch University

Current epidemiological and financial trends suggest there's a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.

The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa. Epa/Maurizio Gambarini

December 21, 2015

How a drug can help prevent 5000 girls being infected with HIV every week

Sinead Delany-Moretlwe, University of the Witwatersrand and Deborah Baron, University of the Witwatersrand

Young women in southern Africa are most at risk of becoming infected with HIV. If they take a pre-exposure prophylaxis like Truvada it could change their lives.

Job Board

Where experts find jobs

More Jobs

Top contributors

Charles Shey Wiysonge
Director, Cochrane South Africa, South African Medical Research Council
Sinead Delany-Moretlwe
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
Deborah Baron
Researcher and Programme Manager: Clinical Research Consortium for Wits Reproductive Health and HIV Institute (RHI), University of the Witwatersrand
Collen Masimirembwa
Honorary Prof. of Clinical Pharmacology,, University of Cape Town